ADiTx Therapeutics Inc. (ADTX): Price and Financial Metrics

ADiTx Therapeutics Inc. (ADTX): $2.03

0.04 (-1.93%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

F

Add ADTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#345 of 360

in industry

ADTX Price/Volume Stats

Current price $2.03 52-week high $68.08
Prev. close $2.07 52-week low $1.95
Day low $2.02 Volume 12,200
Day high $2.06 Avg. volume 278,558
50-day MA $2.61 Dividend yield N/A
200-day MA $7.03 Market Cap 485.17K

ADTX Stock Price Chart Interactive Chart >


ADiTx Therapeutics Inc. (ADTX) Company Bio


ADiTx Therapeutics, Inc. is a preclinical stage, life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies. The firm have worldwide license for commercializing a nucleic acid-based technology, named Apoptotic DNA Immunotherapy (ADi), which utilizes a novel approach that mimics the way the body naturally induces tolerance to its own tissue. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Loma Linda, CA.


ADTX Latest News Stream


Event/Time News Detail
Loading, please wait...

ADTX Latest Social Stream


Loading social stream, please wait...

View Full ADTX Social Stream

Latest ADTX News From Around the Web

Below are the latest news stories about ADITXT INC that investors may wish to consider to help them evaluate ADTX as an investment opportunity.

Why Is Aditxt (ADTX) Stock Up 70% Today?

Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.

William White on InvestorPlace | November 30, 2023

Why Is Connexa Sports Technologies (CNXA) Stock Up 31% Today?

Connexa Sports Technologies stock is rising on a new 5.9% CNXA shareholder and a secondary offering from one of its investors.

William White on InvestorPlace | November 30, 2023

Why Is Redhill Biopharma (RDHL) Stock Down 27% Today?

Redhill Biopharma stock is falling on Thursday as shares of RDHL give up some of the gains they made throughout the week.

William White on InvestorPlace | November 30, 2023

Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today?

Vivos Therapeutics stock is falling on Thursday but that's only after VVOS shares experienced a massive rally on Wednesday!

William White on InvestorPlace | November 30, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!

William White on InvestorPlace | November 30, 2023

Read More 'ADTX' Stories Here

ADTX Price Returns

1-mo -15.06%
3-mo -44.38%
6-mo -42.00%
1-year -91.51%
3-year -99.96%
5-year N/A
YTD -69.38%
2023 -85.64%
2022 -95.69%
2021 -74.23%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!